β2 Integrins are involved in cytokine responses to whole gram-positive bacteria

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 5871-5876

  Cuzzola, Maria ^a   Mancuso, Giuseppe ^a   Beninati, Concetta ^a   Biondo, Carmelo ^a   Genovese, Francesco ^a   Tomasello, Francesco ^a   Flo, Trude H ^b   Espevik, Terje ^b   Teti, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 INTEGRIN; CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; CYTOKINE; INTEGRIN; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CHO CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0034129778     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.5871     Document Type: Article

References (51)

1. Bone, R.C. 1994. Gram positive organisms and sepsis. Arch. Intern. Med. 154:26.
2. Baker, C. J. 1986. Group B streptococcal infections in newborns. N. Engl. J. Med. 314:1702.
3. Verhoef, S., and E. Mattsson. 1995. The role of cytokines in gram-positive bacterial shock. Trends Microbiol. 3:136.
4. Dinarello, C. A. 1991. The proinflammatory cytokines interleukin 1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis. 163: 1177.
5. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437.
6. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249:1431.
7. Ziegler-Heitbrock, H. W. L., and R. J. Ulevitch. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121.
8. Mathison, J. C., P. S. Tobias, E. Wolfson, and R. J. Ulevitch. 1992. Plasma lipopolysaccharide (LPS)-binding protein: a key component in macrophage recognition of gram-negative bacteria. J. Immunol. 149:200.
9. Gupta, D., T. N. Kirkland, S. Viriyakosol and R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:23310.
10. Weidemann, B., H. Brade, E. T. Rietschel, R. Dziarski, V. Bazil, S. Kusumoto, H. D. Flad and A. J. Ulmer. 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62:4709.
11. Weidemann, B., J. Schletter, R. Dziarski, S. Kusumoto, F. Stelter, E. T. Rietschel, H. D. Flad and A. J. Ulmer. 1997. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 or human monocytes. Infect. Immun. 65:858.
12. Cleveland, M. G., J. D. Gorham, T. L. Murphy, E. Tuomanen and K. M. Murphy. 1996. Lipoteichoic acid preparation of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64:1906.
13. Hattor, Y., K. Kasai, K. Akimoto, and C. Thiemermann. 1997. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. Biochem. Biophys. Res. Commun. 233:375.
14. Ofek, I., J. Goldhar, and Y. Keisari. 1995. Nonopsonic phagocytosis of microrganisms. Annu. Rev. Microbiol. 49:239.
15. Dong, Z. M., and J. W. Murphy. 1997. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect. Immun. 65:557.
16. Talamas-Rohana, P., S. D. Wright, M. R. Lennarts, and D. G. Russell. 1990. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p 150,95 and LFA-1 family of leukocyte integrins. J. Immunol. 144:4817.
17. Newman, S. L., S. Chaturvedi, and V. S. Klein. 1995. The W1-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophages CD11b/CD18 (CR3) and CD14. J. Immunol. 154:753.
18. 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:135.
19. Wright, S. D., R. A. Ramos, A. Hermanowski-Vosatka, P. Rockwell, and P. A. Detmers. 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1281.
20. Zarewych, D. M., A. L. Kindzelskii, R. F. Todd III, and H. R. Petty. 1996. LPS induces CD14 association with complement receptor type 3, which is reserved by neutrophil adhesion. J. Immunol. 156:430.
21. Ingalls, R. R., and D. T. Golembock. 1995. CD11c/CD18, transmembrane signalling receptor for lipopolysaccharide. J. Exp. Med. 181:1473.
22. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 395:284.
23. Kirschning, C. J., H. Wesche, T. M. Ayres, and M. Rothe. 1998. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2097.
24. Mancuso, G., V. Cusumano, F. Genovese, M. Gambuzza, C. Beninati, and G. Teti. 1997. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infect. Immun. 65:3731.
25. Mancuso, G., F. Tomasello, I. Ofek, and G. Teti. 1994. Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid. Infect. Immun. 62:1470.
26. von Hunolstein, C., A. Totolian, G. Alfarone, G. Mancuso, V. Cusumano, G. Teti and G. Orefici. 1997. Soluble antigens from group B streptococci induce cytokine production in human blood cultures. Infect. Immun. 65:4017.
27. Teti, G., M. Calapai, G. Calogero, F. Tomasello, G. Mancuso, A. Galli, and G. Riggio. 1992. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci. Hybridoma 11:13.
28. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61:227.
29. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
30. Medvedev, A. E., T. Flo, R. R. Ingalls, D. T. Golenbock, G. Teti, S. N. Vogel, and T. Espevik. 1998. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-κB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol. 160:4535.
31. Golenbock, D. T., Y. Liu, F. H. Millham, M. W. Freeman, and R. A. Zoeller. 1993. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J. Biol. Chem. 268:2055.
32. Delude, R. L., R. Savedra, H. Zhao, R. Thierienger, S. Yamomoto, M. J. Fenton, and D. T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92: 9288.
33. Delfino, D., L. Cianci, E. Lupis, A. Celeste, M. L. Petrelli, F. Currò, V. Cusumano, and G. Teti. 1997. Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect. Immun. 65:2454.
34. Yoshimura, A., E. Lien, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1.
35. Cauwels, A., E. Wan, M. Leismann and E. Tuomanen. 1997. Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by gram-positive bacteria. Infect. Immun. 65:3255.
36. Mattsson, E., H. Van Dijk, K. Van Kessel, J. Verhoef, A. Fleer, and J. Rollof. 1996. Intracellular pathways involved in tumor necrosis factor-α release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar. J. Infect. Dis. 173:212.
37. Katz, S. S., K. Chen, S. Chen, M. E. Doerfler, P. Elsbach, and J. Weiss. 1996. Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin. Infect. Immun. 64:3592.
38. Antal, J. M., J. V. Cunningham, and K. J. Goodrum. 1992. Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three. Infect. Immun. 60:1114.
39. Espevik, T. 1998. Bacterial polysaccharides as cytokine inducers: the involvement of CD14 and CD18. In Septic Shock Caused by Gram-Positive Bacteria. Vibo Valentia Seminars on Shock, October 10-12, 1998. Vibo Valentia, Italy.
40. Goodrum, K. J., L. L. McCornick, and B. Schneider. 1994. Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/ CD18)-dependent. Infect. Immun. 62:3102.
41. Goodrum, K. J., J. Dierksheide, and B. J. Yoder. 1995. Tumor necrosis factor α acts as an autocrine second signal with gamma interferon to induce nitric oxide in group B streptococcus-treated macrophages. Infect. Immun. 63:3715.
42. Belani, K., P. M. Schlievert, E. L. Kaplan, and P. Ferrieri. 1991. Association of exotoxin-producing group A streptococci and severe disease in children. Pediatr. Infect. Dis. 10:351.
43. Hackett, S. P., and D. L. Stevens. 1992. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J. Infect. Dis. 165:879.
44. Stevens, D. L., A. E. Bryant, S. P. Hackett, A. Chang, G. Peer, S. Kosanke, T. Emerson, and L. Hinshaw. 1996. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J. Infect. Dis. 173:619.
45. Eichacker, P. Q., W. D. Hoffman, A. Farese, S. M. Bank, T. Mouginis, S. Richmond, G. C. Kuo, T. J. MacVittie, and C. Natanson. 1992. Leukocyte CD11b/18 antigen directed monoclonal antibody prolongs survival and decreases hypoxemia in canines challenged with tumor necrosis factor. Am. Rev. Respir. Dis. 145:1023.
46. Wright, S. D., S. M. Levin, M. T. J. Jong, Z. Chad, and L. G. Kabbash. 1989. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 169:175.
47. Wright, S. D., P. A. Detmers, Y. Aida, R. Adamowski, D. C. Anderson, Z. Chad, L. G. Kabbash, M. J. Pabst. 1990. CD18-deficient cells respond to lipopolysaccharide in vitro. J. Immunol. 144:2566.
48. Eichacker, P. Q., W. D. Hoffman, A. Farese, R. L. Danner, A. F. Suffredini, Y. Waisman, S. M. Banks, L. Wilson, R. Rothlein, R. J. Elin, et al. 1993. Monoclonal antibody against leukocyte CD11/18 adhesion complex worsens endotoxemia and cardiovascular dysfunction in antibiotic-treated canines with septic shock. J. Appl. Physiol. 74:1885.
49. Freeman, B. D., R. Correa, C. Natanson, W. Karzai, M. Patterson, W. D. Hoffman, S. M. Banks, Y. Fitz, R. L. Danner, and P. Q. Eichacker. 1995. CD11b monoclonal antibody (mAb 1B6) reduces lung injury but shortens survival in antibiotic treated rats during pneumonia. Am. J. Respir. Crit. Care Med. 151:A763.
50. Sharar, S. R., R. K. Winn, C. E. Murray, J. M. Harlan, and C. L. Rice. 1991. A CD18 monoclonal antibody increases the incidence and severity of subcutaneous abscess formation after high-dose Staphylococcus aureus injection in rabbits. Surgery 110:231.
51. Rosen, H., S. Gordon, and R. J. North. 1989. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type III complement receptor of myelomonocytic cells: absence of monocytes at infective foci allow Listeria to multiply in nonphagocytic cells. J. Exp. Med. 170:27.